NO20076675L - Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet - Google Patents

Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet

Info

Publication number
NO20076675L
NO20076675L NO20076675A NO20076675A NO20076675L NO 20076675 L NO20076675 L NO 20076675L NO 20076675 A NO20076675 A NO 20076675A NO 20076675 A NO20076675 A NO 20076675A NO 20076675 L NO20076675 L NO 20076675L
Authority
NO
Norway
Prior art keywords
antibacterial activity
medicaments
humans
warm
bacterial infections
Prior art date
Application number
NO20076675A
Other languages
English (en)
Norwegian (no)
Inventor
Folkert Reck
Marshall Morningstar
Hajnalka Hartl
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20076675L publication Critical patent/NO20076675L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20076675A 2005-05-24 2007-12-27 Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet NO20076675L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68403005P 2005-05-24 2005-05-24
PCT/GB2006/001889 WO2006125974A1 (en) 2005-05-24 2006-05-23 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity

Publications (1)

Publication Number Publication Date
NO20076675L true NO20076675L (no) 2007-12-27

Family

ID=36685663

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076675A NO20076675L (no) 2005-05-24 2007-12-27 Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet

Country Status (14)

Country Link
US (1) US20090131444A1 (pt)
EP (1) EP1891078A1 (pt)
JP (1) JP2008542249A (pt)
KR (1) KR20080016577A (pt)
CN (1) CN101258157A (pt)
AU (1) AU2006250987A1 (pt)
BR (1) BRPI0609887A2 (pt)
CA (1) CA2608072A1 (pt)
IL (1) IL187134A0 (pt)
MX (1) MX2007014507A (pt)
NO (1) NO20076675L (pt)
RU (1) RU2007147413A (pt)
WO (1) WO2006125974A1 (pt)
ZA (1) ZA200709870B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CA2643962A1 (en) * 2006-03-10 2007-09-20 Actelion Pharmaceuticals Ltd Antibiotic compounds
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
JP5171618B2 (ja) 2006-05-26 2013-03-27 富山化学工業株式会社 新規な複素環化合物またはその塩ならびにその中間体
BRPI0712430A2 (pt) * 2006-06-08 2012-07-03 Speedel Experimenta Ag piperidinas 2,5-di-substitìdas.
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
ATE520687T1 (de) 2007-06-15 2011-09-15 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyranderiva e
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
BRPI0920895A8 (pt) 2008-10-07 2017-12-26 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2435596T3 (es) 2008-12-12 2013-12-20 Actelion Pharmaceuticals Ltd. Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
SG10201507846YA (en) * 2010-04-02 2015-10-29 Senomyx Inc Sweet flavor modifier
US8829191B2 (en) * 2011-06-17 2014-09-09 Melanie Simone Ronsheim Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
MY179876A (en) 2011-08-12 2020-11-18 Firmenich Incorporated Sweet flavor modifier
US8933232B2 (en) 2012-03-30 2015-01-13 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
AR090844A1 (es) 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
WO2014152996A1 (en) 2013-03-14 2014-09-25 Cubist Pharmaceuticals, Inc. Crystalline form of a beta-lactamase inhibitor
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
CN103613530B (zh) * 2013-12-02 2015-08-19 江苏弘和药物研发有限公司 一种芴甲氧羰基-3-哌啶醇的合成方法
EP3915975A1 (en) * 2013-12-27 2021-12-01 API Corporation Method for producing 5-hydroxypiperidine-2-carboxylic acid
EA031589B1 (ru) 2014-08-22 2019-01-31 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
WO2016073251A1 (en) 2014-11-07 2016-05-12 Senomyx, Inc. Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
HUE049547T2 (hu) 2016-06-08 2020-10-28 Acraf Új baktériumellenes szerek
EP4295852A2 (en) 2016-07-13 2023-12-27 Syros Pharmaceuticals, Inc. Piperidine derivatives as inhibitors of cyclin dependent kinase 7 (cdk7)
JP7210483B2 (ja) 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
MX2020001352A (es) 2017-08-09 2020-03-20 Denali Therapeutics Inc Compuestos, composiciones y metodos.
SI3676297T1 (sl) * 2017-09-01 2023-12-29 Denali Therapeutics Inc. Spojine, sestavki in postopki
TWI802591B (zh) 2017-09-14 2023-05-21 日商第一三共股份有限公司 具有環狀構造的化合物
CR20210426A (es) 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
DE60125373T2 (de) * 2000-07-26 2007-10-18 Smithkline Beecham P.L.C., Brentford Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
JP2004509885A (ja) * 2000-09-21 2004-04-02 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗菌薬としてのキノリン誘導体
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質

Also Published As

Publication number Publication date
BRPI0609887A2 (pt) 2011-10-11
RU2007147413A (ru) 2009-06-27
IL187134A0 (en) 2008-02-09
EP1891078A1 (en) 2008-02-27
WO2006125974A1 (en) 2006-11-30
KR20080016577A (ko) 2008-02-21
JP2008542249A (ja) 2008-11-27
AU2006250987A1 (en) 2006-11-30
US20090131444A1 (en) 2009-05-21
MX2007014507A (es) 2008-02-07
CN101258157A (zh) 2008-09-03
ZA200709870B (en) 2008-11-26
CA2608072A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
NO20080338L (no) Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
NO20071776L (no) Kinoksaliner som B RAF inhibitorer.
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20073719L (no) Kjemiske forbindelser
NO20082709L (no) Kjemiske forbindelser
NO20074703L (no) Antibakterielle piperidinderivater
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
NO20064584L (no) Tetrahydropyridoindolderivater
NO20070199L (no) Substituerte kinazoloner som anti-kreftmidler
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20082269L (no) Nye piperaziner som antimalariamidler
NO20084257L (no) Diketopiperazin og piperidin derivater som antivirale midler
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20084202L (no) 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer
NO20092691L (no) 4-hydroksy-2-okso-2,3-dihydro-1,3-benzotiazol-7yl-forbindelser for modulering av B2-adrenoreseptoraktivitet
NO20072939L (no) Makroloner - aminosubstituerte kinoloner
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
NO20071245L (no) Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer.
NO20091683L (no) Kjemiske forbindelser
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
NO20070656L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
NO20070566L (no) Azin-karboksamider som antikreftmiddel
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application